08/12/2026
There is a fundamental shift underway in regenerative medicine — and the practices that embrace it now will define the standard of care for years to come. On behalf of Ability Network International, your dedicated regional distributor, I am pleased to introduce you to Platinum Biologics — a physician-centric Group Purchasing Organization (GPO) that is setting a new benchmark for biologics solutions across New York Medicaid and Medicare (Regions A & C) providers.
WHY THIS MATTERS TO YOUR PRACTICE
Your patients deserve the highest-quality biologics, delivered with clinical science to back them up. Platinum Biologics was built with exactly that mission in mind. Unlike commodity distributors, Platinum Biologics operates as a true partner to your practice — providing personalized support in product selection, dosage guidance, patient education, and scientific application every step of the way.
A Resource Unique in the Industry:
Platinum Biologics maintains both a Scientific Board and a Medical Board comprised of accomplished, board-certified MDs — available to discuss protocols, therapeutic dosages, peer-reviewed research, and strategic business matters. This level of clinical infrastructure is rarely accessible to individual practices. As your distributor, Ability Network International brings this entire support system directly to your door.
OUR FEATURED PRODUCT LINES
Wharton’s Jelly — Precision Concentrations for Every Clinical Need
Platinum Biologics offers three distinct concentrations and volumes of Wharton’s Jelly products, each meticulously formulated to address the unique needs of individual patients. Every product is accompanied by a comprehensive molecule concentration chart, tissue weight (mg), volume (mL), and transparent pricing — all in a streamlined one-page clinical synopsis. This is precision medicine made practical: the right product, the right dose, the right outcome.
Nano Xsomes™ — The Gold Standard in Exosome Therapy
Not all exosomes are created equal — and Nano Xsomes stand in a category of their own. As the only exosome product backed by published peer-reviewed studies validating both its